Matthew Shair

Matthew Shair

Oprichter bij NUVALENT, INC.

Vermogen: 112 M $ op 30-04-2024

55 jaar
Consumer Services
Health Technology

Oorsprong van het eerstegraads netwerk van Matthew Shair

EntiteitType entiteitIndustrie
922
College/University Other Consumer Services 922
Public Company Biotechnology 28
7
Private Company Biotechnology 7

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Matthew Shair via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Harvard Medical School College/University

Ricky Sun

Ralph Weissleder

David Scadden

Steven E. Hyman

Jeffrey Flier

D. Gilliland

Ole Isacson

Deborah Miller

Corporate Officer/Principal

Corporate Officer/Principal

Director/Board Member

Doctorate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Graduate Degree

Harvard Business School College/University

David Chen

David Levine

Swati Ajay Piramal

Brock Reeve

Sachin Gupta

Tetsu Onitsuka

Doctorate Degree

Masters Business Admin

Director/Board Member

Undergraduate Degree

Masters Business Admin

Graduate Degree

Miscellaneous Commercial Services

Ralph Weissleder

David Scadden

Steven E. Hyman

Jeffrey Flier

D. Gilliland

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Boston College College/University

Douglas Powers

James Porter

Andrew Nest

Alexandra Balcom

Chairman

Doctorate Degree

Graduate Degree

Masters Business Admin

Investment Banks/Brokers

Sapna R. Srivastava

Ricky Sun

Xiaohui Dong

Molly Wharton

Analyst-Equity

Corporate Officer/Principal

Analyst-Equity

Economist

Miscellaneous Commercial Services

David Chen

Shireen Santosham

Christopher Yip

George Doran

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

Anna Protopapas

David Scadden

Steven E. Hyman

Cameron Wheeler

Graduate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Doctorate Degree

Biotechnology

Ralph Weissleder

David Scadden

Steven E. Hyman

Joseph Pearlberg

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Stanford University College/University

Yuval Grill

Michael Fischbach

Isis Amondi Madison

Kate Jackson Hobbs

Masters Business Admin

Corporate Officer/Principal

Undergraduate Degree

Masters Business Admin

University of Pennsylvania College/University

Shireen Santosham

Swati Ajay Piramal

David Sokoler

Joseph Pearlberg

Undergraduate Degree

Director/Board Member

Undergraduate Degree

Undergraduate Degree

The University of California, San Francisco College/University

D. Gilliland

Michael Fischbach

Joseph Pearlberg

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

Miscellaneous Commercial Services

Andargachew Zelleke

David Scadden

D. Gilliland

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Hospital/Nursing Management

Kenneth R. Chien

Ralph Weissleder

David Scadden

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Founder

INFINITY PHARMACEUTICALS, INC. Pharmaceuticals: Major

James Porter

Joseph Pearlberg

Deborah Miller

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Investment Banks/Brokers

Matthew McLean

Khai-leif Nguyen-hille

Analyst-Equity

Analyst-Equity

Investment Managers

Cameron Wheeler

Joseph Pearlberg

Private Equity Investor

Private Equity Investor

St. Xavier's College (Mumbai) College/University

Sapna R. Srivastava

Swati Ajay Piramal

Undergraduate Degree

Director/Board Member

Pharmaceuticals: Major

Cameron Wheeler

Joseph Pearlberg

Director/Board Member

Director/Board Member

AGIOS PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Scadden

Alexandra Balcom

Director/Board Member

Comptroller/Controller/Auditor

Pharmaceuticals: Major

Bob Jackson

Cameron Wheeler

Director/Board Member

Chairman

Hospital/Nursing Management

Ralph Weissleder

D. Gilliland

Corporate Officer/Principal

Corporate Officer/Principal

University of Lund College/University

David Scadden

Ole Isacson

Doctorate Degree

Doctorate Degree

EDITAS MEDICINE, INC. Biotechnology

Andrew Hack

David Scadden

Director of Finance/CFO

Director/Board Member

SQZ BIOTECHNOLOGIES COMPANY Biotechnology

Sapna R. Srivastava

Alexandra Balcom

Director/Board Member

Corporate Officer/Principal

ARIAD PHARMACEUTICALS, INC. Biotechnology

Anna Protopapas

Christopher Turner

Director/Board Member

Chief Tech/Sci/R&D Officer

Harvard Law School College/University

Andargachew Zelleke

David Levine

Graduate Degree

Graduate Degree

CYCLERION THERAPEUTICS, INC. Pharmaceuticals: Major

Steven E. Hyman

Ole Isacson

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Nnamdi Okike

Rodrigo Martinez

Corporate Officer/Principal

Corporate Officer/Principal

MERSANA THERAPEUTICS, INC. Biotechnology

Anna Protopapas

Andrew Hack

Director/Board Member

Director/Board Member

Biotechnology

Michael Fischbach

Emily Conley

Founder

Chief Executive Officer

Stanford Graduate School of Business College/University

Anna Protopapas

Christopher Yip

Masters Business Admin

Masters Business Admin

University of Cambridge College/University

Douglas A. Melton

Steven E. Hyman

Undergraduate Degree

Graduate Degree

Investment Banks/Brokers

Vikas Mouli

Sebastian Brown

Private Equity Analyst

Analyst-Equity

Investment Managers

Andrew Hack

Ricky Sun

Private Equity Investor

Director/Board Member

Financial Conglomerates

Sapna R. Srivastava

Eugene Weichih Lee

Analyst-Equity

Analyst-Equity

Investment Managers

Sachin Gupta

Josh White

Analyst-Fixed Income

Analyst-Equity

Investment Managers

Andrew Hack

Kate Jackson Hobbs

Portfolio Manager-Equities

Portfolio Manager-Equities

Investment Managers

Sachin Gupta

David Sokoler

Analyst-Equity

Analyst-Equity

EQT Partners Japan KK Investment Managers

Tetsu Onitsuka

Private Equity Investor

Investment Managers

Shannon Vonk

Private Equity Analyst

INNODATA INC. Data Processing Services

Andargachew Zelleke

Director/Board Member

Investment Managers

Tetsu Onitsuka

Private Equity Investor

Investment Managers

Michael Fischbach

Private Equity Investor

Investment Managers

Michael Fischbach

Corporate Officer/Principal

REVOLUTION MEDICINES, INC. Pharmaceuticals: Other

Michael Fischbach

Founder

Biotechnology

Michael Fischbach

Founder

Miscellaneous Commercial Services

Michael Fischbach

Founder

NGM BIOPHARMACEUTICALS, INC. Biotechnology

Michael Fischbach

Consultant / Advisor

ZYMERGEN INC. Miscellaneous Commercial Services

Michael Fischbach

Consultant / Advisor

Internet Software/Services

Gary Liu

Chief Executive Officer

Statistieken

Internationaal

Verenigde Staten 45
Japan 3
China 2
India 2
Zweden 2

Sectoraal

Finance 16
Health Technology 15
Consumer Services 12
Commercial Services 7
Health Services 3

Operationeel

Director/Board Member 241
Corporate Officer/Principal 157
Undergraduate Degree 90
Independent Dir/Board Member 55
Private Equity Investor 47
  1. Beurs
  2. Insiders
  3. Matthew Shair
  4. Bedrijfsconnecties